BioNexus Gene Lab Corp (BGLC) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $9.25M | -11.3% |
| 2024 | $10.43M | -8.5% |
| 2023 | $11.40M | +30.4% |
| 2022 | $8.74M | -8.7% |
| 2021 | $9.57M | -5.3% |
| 2020 | $10.12M | +721.6% |
| 2019 | $1.23M | -25.5% |
| 2018 | $1.65M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $9.25M | -11.3% |
| 2024 | $10.43M | -8.5% |
| 2023 | $11.40M | +30.4% |
| 2022 | $8.74M | -8.7% |
| 2021 | $9.57M | -5.3% |
| 2020 | $10.12M | +721.6% |
| 2019 | $1.23M | -25.5% |
| 2018 | $1.65M | — |